Skip to main
SBRA
SBRA logo

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 0%
Buy 38%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT Inc. has shown continued improvements in occupancy and rent coverage, which contribute positively to the company's financial stability and growth potential. The anticipated recovery in the seniors housing managed portfolio is expected to enhance Sabra's leverage profile and enable the pursuit of accretive growth opportunities, supported by favorable healthcare real estate demand drivers. Additionally, the adjustment of 2025 funds from operations (FFO) estimates to $1.54 per share reflects proactive financial management and increasing investment volume, thereby bolstering the company's overall outlook.

Bears say

Sabra Health Care REIT faces challenges due to the unpredictable performance of its individual operators, particularly as some continue to struggle with rent payments amid inflationary pressures. Additionally, the company is not as low-leveraged as several of its peers, which may pose further risk to its financial stability. Furthermore, with its stock trading near the high end of its 10-year valuation range, the current cost of equity indicates limited potential for immediate earnings growth from acquisitions in a competitive healthcare REIT sector.

SBRA has been analyzed by 8 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 38% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 8 analysts, SBRA has a Hold consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.